Vanguard Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2B | Buy |
|
|||||
|
2025
Q1 | $13.2B | Buy |
|
|||||
|
2024
Q4 | $10.7B | Buy |
|
|||||
|
2024
Q3 | $9.67B | Buy |
|
|||||
|
2024
Q2 | $7.91B | Buy |
|
|||||
|
2024
Q1 | $8.4B | Buy |
|
|||||
|
2023
Q4 | $9.06B | Buy |
|
|||||
|
2023
Q3 | $8.37B | Sell |
|
|||||
|
2023
Q2 | $8.74B | Buy |
|
|||||
|
2023
Q1 | $9.37B | Buy |
|
|||||
|
2022
Q4 | $9.62B | Sell |
|
|||||
|
2022
Q3 | $6.91B | Buy |
|
|||||
|
2022
Q2 | $6.82B | Buy |
|
|||||
|
2022
Q1 | $6.28B | Sell |
|
|||||
|
2021
Q4 | $7.68B | Buy |
|
|||||
|
2021
Q3 | $7.35B | Buy |
|
|||||
|
2021
Q2 | $7.23B | Buy |
|
|||||
|
2021
Q1 | $6.74B | Buy |
|
|||||
|
2020
Q4 | $5.99B | Buy |
|
|||||
|
2020
Q3 | $6.49B | Sell |
|
|||||
|
2020
Q2 | $8.06B | Sell |
|
|||||
|
2020
Q1 | $8.01B | Buy |
|
|||||
|
2019
Q4 | $6.74B | Buy |
|
|||||
|
2019
Q3 | $6.5B | Buy |
|
|||||
|
2019
Q2 | $6.9B | Buy |
|
|||||
|
2019
Q1 | $6.59B | Buy |
|
|||||
|
2018
Q4 | $6.28B | Buy |
|
|||||
|
2018
Q3 | $7.5B | Buy |
|
|||||
|
2018
Q2 | $6.81B | Buy |
|
|||||
|
2018
Q1 | $7.17B | Buy |
|
|||||
|
2017
Q4 | $6.79B | Buy |
|
|||||
|
2017
Q3 | $7.66B | Buy |
|
|||||
|
2017
Q2 | $6.57B | Buy |
|
|||||
|
2017
Q1 | $6.16B | Buy |
|
|||||
|
2016
Q4 | $6.05B | Buy |
|
|||||
|
2016
Q3 | $6.57B | Buy |
|
|||||
|
2016
Q2 | $6.87B | Sell |
|
|||||
|
2016
Q1 | $7.69B | Sell |
|
|||||
|
2015
Q4 | $8.66B | Buy |
|
|||||
|
2015
Q3 | $8.34B | Buy |
|
|||||
|
2015
Q2 | $9.81B | Buy |
|
|||||
|
2015
Q1 | $8.21B | Buy |
|
|||||
|
2014
Q4 | $7.69B | Buy |
|
|||||
|
2014
Q3 | $8.44B | Buy |
|
|||||
|
2014
Q2 | $6.53B | Buy |
|
|||||
|
2014
Q1 | $5.48B | Buy |
|
|||||
|
2013
Q4 | $5.62B | Buy |
|
|||||
|
2013
Q3 | $4.62B | Buy |
|
|||||
|
2013
Q2 | $3.69B | Buy |
|